Cargando…
Is There Heterogeneity on Outcome of Hospitalized Heart Transplant Patients with COVID-19 Infection Across the US?
PURPOSE: The COVID-19 pandemic infected large portions of the US community and infected many heart transplant (HTx) patients but in distinct geographical patterns. HTx programs have reported mortality in the range of 23-29% (East Coast of the US) and in non-transplant patients in the range of 15-17%...
Autores principales: | Patel, J., Kittleson, M., Singer-Englar, T., Patel, N., Pena, J., Mohanty, A., Megna, D., Czer, L., Zabner, R., Zakowski, P., Kobashigawa, J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988619/ http://dx.doi.org/10.1016/j.healun.2022.01.812 |
Ejemplares similares
-
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
por: Vaidya, Gaurang, et al.
Publicado: (2020) -
Temporary Mechanical Circulatory Support in Patients with Cardiogenic Shock: Clinical Characteristics and Outcomes
por: Abiragi, Michael, et al.
Publicado: (2023) -
Early Denervation and Later Reinnervation of the Heart Following Cardiac Transplantation: A Review
por: Awad, Morcos, et al.
Publicado: (2016) -
Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients
por: Awad, Morcos Atef, et al.
Publicado: (2019) -
Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart
por: Stern, Lily K., et al.
Publicado: (2023)